This information sheet discusses treatment for latent TB infection. It reminds patients to keep their weekly medical visits, explains directly observed therapy, provides a list of items to discuss with their doctor, a medication schedule, and advises them to call the doctor immediately if they...
This handout contains information for patients that are prescribed the 4-month daily regimen of rifampin (4R) for the treatment of latent TB infection. The handout includes space to record the patient's doctor/clinic contact information.
This information sheet discusses the challenges and key issues of the co-infection of TB and HIV. It states that TB is the leading cause of the death among people with HIV.
This report summarizes an epidemiologic investigation of TB by hospital infection control, infectious disease, and employee services staff at a New York hospital. It presents information on 32 inpatients, diagnosed during January 1991 to March 1992 with multidrug-resistant Mycobacterium TB (MDR-TB)...
This report in the form of a notice to readers states that CDC in conjunction with the American Thoracic Society expects to issue new guidelines on screening and preventive therapy for TB that will include a recommendation on the use of the two-month regimen of daily rifampin and pyrazinamide (2RZ)...
This report describes the investigations of two TB outbreaks that occurred in two state correctional institutions with dedicated HIV housing units. In each outbreak, IS6110-based DNA fingerprinting of Mycobacterium (MTB) isolates linked all cases. During the 4-month intervals between identification...
Because TB treatment is inextricably involved in a host of psychological, social, and economic problems, this manual was developed to help providers establish and enhance social support services in a TB clinic. The purpose of the manual is to help the worker establish social services, develop a...
This report provides recommendations from the Advisory Council for the Elimination of TB (ACET) concerning TB elimination in low-incidence areas. In 1999, ACET called for a renewed commitment to its strategic plan, originally published in 1989 with a year 2000 objective of 3.5 cases per 100,000...
This report provides provisional CDC guidelines for FDA-approved and unapproved, or off-label, uses of bedaquiline in certain populations who were not included in the clinical trials for the drug. These guidelines are intended for health-care professionals who might use bedaquiline for the treatment...
This report summarizes provisional TB surveillance data reported to CDC’s National Tuberculosis Surveillance System in 2012. A total of 9,951 new TB cases were reported for an incidence of 3.2 cases per 100,000 population, which is a decrease of 6.1 percent from the incidence in 2011. TB incidence...
